NEW YORK (GenomeWeb) – Cofactor Genomics announced today that it has partnered with the National Cancer Institute (NCI), in addition to agreements with three other unnamed academic and pharma groups, to demonstrate the clinical utility of Cofactor's RNA-based immune-profiling assay, Cofactor Paragon.

Under the terms of their material transfer agreement, the collaborators will use clinical specimens from several of NCI's clinical trials to validate the Paragon assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.